The Franklin Templeton ETF Trust - Franklin Genomic Advancements ETF (HELX) is an international index fund from (United States) with a market capitalization of $ 22.17 M.
The current price of HELX is $ 34.09, and its performance over the last 12 months was 19.75%. Investors who bought this ETF a year ago achieved a return of 0.1975%.
Investing in Franklin Templeton ETF Trust - Franklin Genomic Advancements ETF can be done through brokerages with access to the international market or, when available, via BDRs in Brazil.